Labiana takes its new line of products for women's health and wellness to CPHI
- Labiana will present two food supplements and one cosmetic product.
- This new product line is in an advanced stage of development and will soon be available in markets such as Europe, Latin America, and the Middle East.
Madrid, October 28, 2025 – Labiana, the pharmaceutical laboratory specializing in animal and human health and listed on BME Growth, will bring its new line of products for women’s health and wellness to CPHI, the most important annual trade fair in the pharmaceutical sector, taking place from October 28 to 30 in Germany.
Specifically, Labiana — which specializes in the development and manufacturing of both its own products and those for third parties (CDMO) — will present, as part of its human health portfolio, two food supplements and one cosmetic product.
Among the food supplements, one is designed to support and contribute to urinary function, considering that between 50% and 80% of women have suffered from urinary tract infections at some point in their lives, with the problem recurring in 25–30% of cases. The second is a vitamin supplement designed to provide comprehensive nutritional support for women during pregnancy and from the moment they begin planning it.
This new product line, currently in an advanced stage of development, is led by Labiana’s Business Development team, which is also working on its distribution. The main target market will be Europe, although commercialization will be global, with priority also given to regions such as Latin America and the Middle East.
These launches are part of Labiana’s consolidated strategic plan and its human health product pipeline, focused on addressing current needs — particularly women’s health, one of the fastest-growing markets in the pharmaceutical industry according to a McKinsey study.
José Manuel García Plaza, Head of Business for Labiana’s Human Health Division, stated:
“CPHI is the world’s largest trade fair in the pharmaceutical industry and an unparalleled setting to present our new line of products specialized in women’s health. Women experience major changes throughout their lives, and at Labiana we want to accompany them at every stage of their health and well-being.”
About Labiana
Labiana Health is a leading independent and fully integrated international laboratory specializing in animal and human health. It offers a diversified portfolio of products and business lines, along with a broad client base built on long-standing relationships of trust. The company has subsidiaries in Spain, Serbia, Turkey, and Mexico, and production centers located in Spain and Serbia.
Labiana’s products are present in more than 150 markets, with proprietary product registrations in over 90 countries. The group operates through two distinct yet complementary business lines: contract manufacturing in both veterinary and human health — providing stability and revenue visibility — and the development, manufacturing, and marketing of its own products for both animal and human health, which drive growth.
The company made its debut on BME Growth in June 2022, becoming the first veterinary company to be listed on the BME Growth Market in Spain.
Leave a Comment